Cooperating for better care.

Eli Lilly

Tag Archives

Confidence grows about Alzheimer’s drugs


Top Alzheimer’s Disease researchers are becoming more confident  about producing effective  pharmaceutical treatments.

If they do, of course, it would obviously have huge effects on the healthcare system.

Reports reports that new experimental drugs from Eli Lilly and Co. and Biogen “have shown promise in slowing down the progression of the mind-wasting disease, attracting the attention of investors and patients.

“Those drugs are still very early in their development and could still join the scrap heap. But the field has gained a major understanding of how the brain changes with Alzheimer’s and better insight on how and when to intervene medically.”

The Lilly and Biogen drugs block beta amyloid, a protein that causes toxic brain plaques that are markers of the  disease.

“‘This year is different because multiple mechanisms are being explored and there’s a tremendous revival of faith in the anti-amyloid approach,’ said Reisa Sperling, M.D., director of the Center for Alzheimer’s Research at the Harvard Medical School, told Reuters.

An officially estimated 5 million people have the disease in the United States, but some experts think that the real number is considerably higher. The Alzheimer’s Association projects that up  28 million Americans will develop the disease by 2050 and eat up 25 percent of Medicare spending by 2040.

That is, unless effective drugs are found.




Mickey Mouse, M.D.

(Video included in link.)

Lisa Suennen  writes in MedCity News:

”I expect we are going to see a lot more collaborations between healthcare and consumer products companies like unlikely alliances {one between Disney and Eli Lilly} that go at the core of two of the most serious healthcare challenges: health literacy and behavior change.

”If we could ‘fix’ those two problems, I suspect that we could cut the costs of the healthcare system by at least a third by eliminating many of the medical errors, treatment compliance problems borne of lack of understanding and cultural medical miscues.”

”Healthcare companies had better co-opt those consumer brand companies into helping them communicate with consumers or they may just end up working for them.”

Contact Info

(617) 230-4965

Wellesley, Mass